Literature DB >> 5768100

Effect of a new series of bicyclic compounds with potential thymoleptic properties on the reserpine-resistant uptake mechanism of central and peripheral monoamine neurones in vivo and in vitro.

A Carlsson, K Fuxe, B Hamberger, T Malmfors.   

Abstract

1. Bicyclic compounds with potential thymoleptic properties (Lu-compounds) have recently become available, and their effects on the membrane pumps of the central and peripheral monoamine neurones have now been tested and compared with those of the tricyclic antidepressant drugs.2. Biochemical and histochemical in vivo studies have been performed. The possible blocking action of Lu-compounds on the noradrenaline (NA) and 5-hydroxytryptamine (5-HT) displacement caused by 4,alpha-dimethyl-metatyramine (H 77/77) and 4-methyl-alpha-ethyl-meta-tyramine (H 75/12), respectively, has been studied, and a positive result has been taken as evidence for membrane pump blocking activity. No certain effects were obtained on the 5-HT displacement induced by H 75/12, whereas a partial blockade of the NA displacement by H 77/77 in central NA neurones was obtained after most of the Lu-compounds (Lu-3-010, 3-049, 3-092, 4-012) and especially after the thiophthalane derivative Lu 5-003. The ED50 of the latter drug was around 8 mg/kg, that is, somewhere between protriptyline (ED50 4 mg/kg) and desipramine (ED50 15 mg/kg) in potency.3. Histochemical in vivo studies on the rat iris revealed that Lu 5-003 and especially the corresponding phthalane derivative Lu 3-010 were potent in blocking the uptake of alpha-methyl-NA in the adrenergic nerve terminals of the iris. The other Lu-compounds were less active. The releasing effects of the Lu-compounds on the extragranular accumulation of alpha-methyl-NA in the adrenergic terminals were weak compared with membrane blocking activity.4. In vitro studies on the central and peripheral catecholamine (CA) neurones have also been performed. In the same way as, for example, protriptyline the Lu-compounds only blocked accumulation of alpha-methyl-NA in the NA terminals but not in the dopamine (DA) nerve terminals. Lu 5-003 and Lu 3-010 were the most potent of the Lu-drugs when added in vitro. The Lu-drugs were also injected in vivo after which the effect on the alpha-methyl-NA accumulation was studied in vitro. In isotope experiments with labelled alpha-methyl-NA it was found that desipramine, Lu-3-010, Lu 3-092 and Lu 4-012 were equally potent in blocking uptake in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5768100      PMCID: PMC1703539          DOI: 10.1111/j.1476-5381.1969.tb08299.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  In-vivo decarboxylation of alpha-methyl DOPA and alpha-methyl metatyrosine.

Authors:  A CARLSSON; M LINDQVIST
Journal:  Acta Physiol Scand       Date:  1962-01

2.  A method for the fluorimetric determination of adrenaline and noradrenaline in tissues.

Authors:  A BERTLER; A CARLSSON; E ROSENGREN
Journal:  Acta Physiol Scand       Date:  1958-12-15

3.  Pharmacological studies of a new series of bicyclic thymoleptics.

Authors:  P V Petersen; N Lassen; V Hansen; T Huld; J Hjortkjaer; J Holmblad; I M Nielsen; M Nymark; V Pedersen; A Jorgensen; W Hougs
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1966

4.  Inhibition of amine uptake in the mouse heart by some new "thymoleptic" drugs.

Authors:  B Waldeck
Journal:  J Pharm Pharmacol       Date:  1968-02       Impact factor: 3.765

5.  Combined fluorescence histochemistry and 3H-noradrenaline measurements of adrenergic nerves.

Authors:  L Olson; B Hamberger; G Jonsson; T Malmfors
Journal:  Histochemie       Date:  1968

6.  A modification of the histochemical fluorescence method for the improved localization of 5-hydroxytryptamine.

Authors:  K Fuxe; G Jonsson
Journal:  Histochemie       Date:  1967

7.  Reserpine-resistant uptake of catecholamines in isolated tissues of the rat. A histochemical study.

Authors:  B Hamberger
Journal:  Acta Physiol Scand Suppl       Date:  1967

8.  Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons.

Authors:  A Carlsson; K Fuxe; B Hamberger; M Lindqvist
Journal:  Acta Physiol Scand       Date:  1966 Jul-Aug

9.  Lu 3-olo (3,3 dimethyl-1-phenyl-1,3 methylaminopropylphthalane): pharmacological profile.

Authors:  I M Nielsen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1967

10.  A fluorimetric method for the determination of dopamine (3-hydroxytyramine).

Authors:  A CARLSSON; B WALDECK
Journal:  Acta Physiol Scand       Date:  1958-12-15
View more
  6 in total

1.  Acute and chronic effects of 4-chloroamphetamine on monoamine metabolism in the rat brain.

Authors:  B E Leonard
Journal:  Psychopharmacologia       Date:  1976

2.  Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171.

Authors:  J Hyttel
Journal:  Psychopharmacology (Berl)       Date:  1977-03-16       Impact factor: 4.530

3.  Potentiation of ocular response to adrenaline by 3,3-dimethyl-1-(3-methylaminopropyl)-1-phenylphthalan (Lu 3-010) and a thiophthalan analogue (Lu 5-003): blockers of catecholamine uptake.

Authors:  W Lippmann
Journal:  Experientia       Date:  1971-08

4.  Some neurochemical effects of amphetamine, methylamphetamine and p-bromomethylamphetamine in the rat.

Authors:  B E Leonard; S A Shallice
Journal:  Br J Pharmacol       Date:  1971-02       Impact factor: 8.739

5.  Effect of p-nitromethylamphetamine on biogenic amines and their amino-acid precursors in rat brain.

Authors:  B E Leonard; S A Shallice
Journal:  Br J Pharmacol       Date:  1971-12       Impact factor: 8.739

6.  Saturated oxygen and nitrogen heterocycles via oxidative coupling of alkyltrifluoroborates with alkenols, alkenoic acids and protected alkenylamines.

Authors:  Jonathan M Shikora; Chanchamnan Um; Zainab M Khoder; Sherry R Chemler
Journal:  Chem Sci       Date:  2019-08-19       Impact factor: 9.825

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.